跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RILEXINE CHEWABLE TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RILEXINE CHEWABLE TABLETS
Authorized
STANDARD
RILEXINE CHEWABLE TABLETS
VIRBAC AH, INC.
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
3fc783ccba6a68ca
Company
VIRBAC AH, INC.
Type
Standard
Approval Details
Approval Id
3fc783ccba6a68ca
Drug Approval Canada Name
RILEXINE CHEWABLE TABLETS
Product Name
RILEXINE CHEWABLE TABLETS
Status
Marketed
Status Date
2022-02-23
Original Market Date
2022-02-23
Din
02442701
Drug Class
Veterinary
Dosage Form
Tablet (Chewable)
Route Of Administration
Oral
Schedule
Prescription
Atc Original
Not Applicable
Aig Number
0105911007
Company Name
VIRBAC AH, INC.
Company Address
Po Box/Cp 162059 Fort Worth Texas United States 76161
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
3fc783ccba6a68ca
Type
Standard
Back to Health Canada Approvals